Should the c100 antigen be removed from HCV antibody assays?

H. L. Zaaijer, H. T. Cuypers, H. W. Reesink, P. N. Lelie

Other Departments

Research output: Contribution to journal › Comment/Letter to the editor › Academic

10 Citations (Scopus)

Original language	English
Pages (from-to)	150
Journal	Vox sanguinis
Volume	66
Issue number	2
DOIs	https://doi.org/10.1111/j.1423-0410.1994.tb00299.x
Publication status	Published - 1994

Access to Document

https://doi.org/10.1111/j.1423-0410.1994.tb00299.x

Cite this

@article{b66b92ee4ef04220839aa05cebbb3edb,

title = "Should the c100 antigen be removed from HCV antibody assays?",

author = "Zaaijer, {H. L.} and Cuypers, {H. T.} and Reesink, {H. W.} and Lelie, {P. N.}",

year = "1994",

doi = "https://doi.org/10.1111/j.1423-0410.1994.tb00299.x",

language = "English",

volume = "66",

pages = "150",

journal = "Vox sanguinis",

issn = "0042-9007",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Should the c100 antigen be removed from HCV antibody assays?

AU - Zaaijer, H. L.

AU - Cuypers, H. T.

AU - Reesink, H. W.

AU - Lelie, P. N.

PY - 1994

Y1 - 1994

U2 - https://doi.org/10.1111/j.1423-0410.1994.tb00299.x

DO - https://doi.org/10.1111/j.1423-0410.1994.tb00299.x

M3 - Comment/Letter to the editor

C2 - 7514326

SN - 0042-9007

VL - 66

SP - 150

JO - Vox sanguinis

JF - Vox sanguinis

IS - 2

ER -